ProstaLund
0,493 SEK -0,2%Vær den første som følger denne virksomhed
ProstaLund operates in medical technology. Today, specialisation is mainly in the area of treatment of benign prostate enlargement (BPH). Through the company CoreTherm, heat treatment of benign prostate enlargement is offered, without the need for surgical operation. The vision is to offer both faster and more efficient solutions against traditional forms of infestation. The company was founded in 1991 and is operating globally, based in Lund.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
PLUN
Daglig lav / høj pris
0,471 / 0,494
SEK
Markedsværdi
60,66 mio. SEK
Aktieomsætning
49,67 t SEK
Volumen
104 t
Finanskalender
Delårsrapport
19.08.2024
Delårsrapport
07.11.2024
Årsrapport
20.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Mats Alyhr | 20,5 % | 20,5 % |
BFCM P/C BFCM Sweden Retail LT | 8,8 % | 8,8 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
New agreement - MR Prof. Dr Karl Diehl starts up with CoreTherm® treatments in Austria
ProstaLund AB - Interim report January-March 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools